A New Method for Ileostomy Output Collection Using an Intestinal Tampon
NCT ID: NCT06897163
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2024-12-10
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Can participants successfully self-insert the intestinal tampon?
* What is the level of discomfort or pain associated with the insertion and use of the tampon?
Researchers will compare different tampon designs and coatings to find the most suitable one for insertion and retention. Participants will:
* Be observed and interviewed during the insertion of the tampon by a medical consultant.
* Self-insert the tampon under supervision and later independently.
* Provide feedback on their experience, including any discomfort or pain using a numerical rating scale (NRS).
* Provide stool samples before and after using the tampon for microbiome analysis.
This study aims to determine the feasibility and user acceptance of the intestinal tampon as an alternative to traditional stoma bags, potentially reducing complications and improving the quality of life for people with an ileostomy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
New Method for the Collection of the Output From the Ileostoma Using a Intestinal Tampon
NCT05891041
Novel Post-Surgical Incision Management to Prevent Ostomy Complications
NCT06524401
An Explorative Randomized Controlled Investigation Evaluating Newly Developed Ostomy Products
NCT02351817
Safety and Performance of New 1-piece Ostomy Product
NCT01800916
Multi-national, Safety and Performance Study of New Ostomy Product Compared to Standard Care
NCT01517178
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Background and Rationale Approximately 1 million people worldwide live with an ileostomy, relying on stoma bags to collect liquid stool. Despite innovations in materials and design, stoma bags still cause significant physical and mental discomfort. Issues include the unsightly appearance of the bag, leakage, noise, and skin irritation. These problems can lead to a reduced quality of life and increased healthcare costs due to skin complications.
The specialized absorbent intestinal tampon is hypothesized to be a discreet and effective alternative to stoma bags. It is designed to be self-inserted by the user, absorb liquid stool, and reduce the complications associated with stoma bags. Previous studies have shown that the tampon can be safely inserted by a healthcare professional, and this study aims to determine if users can safely and effectively insert the tampon themselves.
Study Design and Methods The study is a continuation of a proof-of-concept trial with a qualitative design. It involves observing and interviewing participants during the insertion of the tampon, both by a medical consultant and by the participants themselves. The study will test different tampon designs and coatings to find the most suitable one for insertion and retention.
Participants:
10 individuals with ileostomies, previously screened and included in the study. Inclusion criteria: Age ≥ 18 years, ileostomy \> 6 months old, written informed consent, stoma opening ≥ 10 mm in diameter.
Exclusion criteria: Difficulty understanding study information, somatic illness, active inflammatory bowel disease, hernia around the stoma, daily output \> 2 liters, active inflammation in the ileum.
Procedures:
Day 1:
Participants arrive at the study site. A medical consultant inserts the tampon and observes the participant. Participants then self-insert the tampon under supervision. The procedure is repeated with different tampon designs, up to three times.
Day 2:
Participants self-insert the tampon using the best method from Day 1. Stool samples are collected before and after tampon use for microbiota analysis.
Participants are interviewed about their experience, including any discomfort or pain using a numerical rating scale (NRS).
The tampon remains in place for up to 6 hours, with participants free to move and eat.
The tampon is removed, and another stool sample is collected. Further testing and iterations may be conducted at home with detailed documentation and follow-up interviews.
Data Collection:
Qualitative data from interviews and observations. Quantitative data from NRS scores for pain and discomfort. Microbiota analysis of stool samples before and after tampon use.
Risks and Benefits The study aims to minimize any discomfort or complications associated with the tampon. Previous safety data indicate no serious risks, but participants are trained and supervised during insertion. Potential risks include pain during insertion, expansion, or removal of the tampon, and rare complications such as tampon retention or perforation.
The potential benefits of the study are significant, as the tampon could provide a more discreet and comfortable alternative to stoma bags, improving the quality of life for individuals with ileostomies.
Ethical Considerations The study adheres to ethical guidelines, including informed consent, data protection, and participant safety. Results will be published in a peer-reviewed journal and on the sponsor's website, regardless of the outcome.
Conclusion This study aims to provide valuable insights into the feasibility and user acceptance of a specialized absorbent intestinal tampon for ileostomy patients. By addressing the limitations of traditional stoma bags, the tampon has the potential to significantly improve the quality of life for individuals with ileostomies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Specialized Absorbent Intestinal Tampon Group
Participants in this arm will receive the specialized absorbent intestinal tampon designed to collect ileostomy output. The study will evaluate the feasibility, safety, and user acceptance of the tampon.
Specialized Absorbent Intestinal Tampon
The specialized absorbent intestinal tampon is designed to be self-inserted by participants with ileostomies. It aims to collect ileostomy output and improve the quality of life by reducing complications associated with traditional stoma bags. The study will test different tampon designs and coatings to find the most suitable one for insertion and retention. Participants will be observed and interviewed during the insertion process, and their feedback on discomfort or pain will be collected using a numerical rating scale (NRS). Stool samples will be collected before and after tampon use for microbiota analysis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Specialized Absorbent Intestinal Tampon
The specialized absorbent intestinal tampon is designed to be self-inserted by participants with ileostomies. It aims to collect ileostomy output and improve the quality of life by reducing complications associated with traditional stoma bags. The study will test different tampon designs and coatings to find the most suitable one for insertion and retention. Participants will be observed and interviewed during the insertion process, and their feedback on discomfort or pain will be collected using a numerical rating scale (NRS). Stool samples will be collected before and after tampon use for microbiota analysis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ileostomy \> 6 months old
* Stoma opening ≥ 10 mm in diameter
* Written informed consent
Exclusion Criteria
* Somatic illness, including active inflammatory bowel disease
* Hernia around the stoma
* Daily output \> 2 liters
* Active inflammation in the ileum (diagnosed within 2 months before the study day)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ampa Medical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cecilie Ammitzbøll
Medical doctor (MD, PhD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ampa Medical
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-23000001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.